journal article·2013-02

Superparamagnetic iron oxide and drug complex-embedded acoustic droplets for ultrasound targeted theranosis

Chung-Hsin Wang, Shih-Tsung Kang, Chih-Kuang Yeh

Biomaterials· Volume 34· Issue 7
Publisher page

Abstract

Ultrasound-triggered acoustic droplet vaporization (ADV) has been reported as a mechanical and chemical theranostic strategy for tumor treatment. However, targeting of sufficient amounts of droplets to solid tumors to direct effective mechanical force toward tumor cells remains a major challenge. In this study, we incorporated superparamagnetic iron oxide (SPIO) nanoparticles into acoustic droplets to allow both magnetism-assisted targeting and magnetic resonance (MR)-guided ultrasound-triggered ADV. The multi-functionality of these droplets was further increased by co-encapsulation of the chemotherapeutic drug doxorubicin (DOX) and surface conjugation of anti-vascular endothelial growth factor receptor 2 antibody, to serve as an additional targeting moiety. Maximum loading capacities of 7.69 mg SPIO and 1.53 mg DOX per mL were achieved, and magnetic properties were characterized by determination of magnetic hysteresis curves and transverse relaxation rates. In vitro and in vivo MR imaging demonstrated the feasibility of dual modal imaging of SPIO-embedded droplets. Finally, a vessel-mimicking phantom model with live C6 glioma cells was used to demonstrate a 5.4-fold improvement in targeting efficacy by magnetism-assisted targeting of the SPIO-embedded droplets, and effective disruption of cells by insonation-induced ADV, suggesting the potential of developing this system for future clinical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Photoacoustic and Ultrasonic Imaging · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (41)

Show source-provided references
1. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery10.1146/annurev.bioeng.8.061505.095852 ↗
2. Ultrasound mediated delivery of drugs and genes to solid tumors10.1016/j.addr.2008.03.007 ↗
3. MRI-guided gas bubble enhanced ultrasound heating in in vivo rabbit thigh10.1088/0031-9155/48/2/306 ↗
4. Enhancement of ultrasound contrast agent in high-intensity focused ultrasound ablation10.1007/BF02850207 ↗
5. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment10.1016/j.biomaterials.2011.09.096 ↗
6. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery
7. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain10.1073/pnas.1003388107 ↗
8. Non-invasive opening of BBB by focused ultrasound
9. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications10.1097/01.rli.0000199292.88189.0f ↗
10. Dissolution behavior of lipid monolayer-coated, air-filled microbubbles: effect of lipid hydrophobic chain length10.1021/la026082h ↗
11. Driving delivery vehicles with ultrasound10.1016/j.addr.2008.03.002 ↗
12. Acoustic droplet vaporization for therapeutic and diagnostic applications10.1016/S0301-5629(00)00262-3 ↗
13. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting10.1143/JJAP.44.4548 ↗
14. The role of inertial cavitation in acoustic droplet vaporization10.1109/TUFFC.2009.1132 ↗
15. Initial investigation of acoustic droplet vaporization for occlusion in canine kidney10.1016/j.ultrasmedbio.2010.06.020 ↗
16. In vivo droplet vaporization for occlusion therapy and phase aberration correction10.1109/TUFFC.2002.1009331 ↗
17. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles10.1016/j.jconrel.2009.05.026 ↗
18. Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion10.1016/j.ultrasmedbio.2010.04.019 ↗
19. Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis10.1016/j.biomaterials.2011.11.036 ↗
20. Theranostic Gd(III)-lipid microbubbles for MRI-guided focused ultrasound surgery10.1016/j.biomaterials.2011.09.026 ↗
21. Non-viral VEGF(165) gene therapy–magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model10.1111/j.1582-4934.2008.00592.x ↗
22. Enhancement of gas-filled microbubble R2* by iron oxide nanoparticles for MRI10.1002/mrm.22184 ↗
23. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging10.1016/j.biomaterials.2009.03.051 ↗
24. Iron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imaging10.1016/j.biomaterials.2011.05.019 ↗
25. Two-in-one" fabrication of Fe3O4/MePEG-PLA composite nanocapsules as a potential ultrasonic/MRI dual contrast agent10.1021/la202096x ↗
26. Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells10.1021/la202679p ↗
27. Encapsulation of magnetic and fluorescent nanoparticles in emulsion droplets10.1021/la047025m ↗
28. Giant vesicles containing magnetic nanoparticles and quantum dots: feasibility and tracking by fiber confocal fluorescence microscopy10.1002/anie.200700581 ↗
29. Tumor angiogenesis: therapeutic implications10.1056/NEJM197111182852108 ↗
30. VEGF regulates cell behavior during vasculogenesis10.1006/dbio.2000.9744 ↗
31. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis
32. Molecular vehicles for targeted drug delivery10.1021/bc0155770 ↗
33. VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy10.1007/s11051-011-0300-8 ↗
34. Multi-functional polymeric nanoparticles for tumour-targeted drug delivery10.1517/17425247.3.2.205 ↗
35. Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth10.1158/1078-0432.CCR-11-1102 ↗
36. Intracellular acoustic droplet vaporization in a single peritoneal macrophage for drug delivery applications10.1021/la203212p ↗
37. Engineered nanocarriers of doxorubicin: a current update10.1615/CritRevTherDrugCarrierSyst.v25.i1.10 ↗
38. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: part I – formulation development and in-vitro characterization10.1016/j.jconrel.2009.12.026 ↗
39. Interaction of doxorubicin with phospholipid monolayer and liposomes10.1016/S0301-4622(97)00125-7 ↗
40. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle10.1016/j.jconrel.2006.12.015 ↗
41. Microbubble tunneling in gel phantoms10.1121/1.3097679 ↗